PARP inhibitors in recent years have significantly improved care for ovarian cancer. However, not all patients benefit and some develop resistance over time.
Researchers conducted a comprehensive search of PubMed, Embase and the Cochrane Library to identify randomized controlled trials utilizing botox for AGA treatment.